Catherine Goodman: The story of the Affordable Medicines Facility - malaria
This discussion is centered on surveys recently done on accessibility to anti-malarial drugs globally and artemisinin-based combination therapies (ACTs). ACTs which have been highly effective are recommended treatment for malaria but despite free or highly subsidised public sector provision, access is still poor. Catherine Goodman discusses survey results on uptake, accessibility, pricing, subsidies, supply chains and supporting interventions to ensure effective ACT scale-up. These surveys were conducted by the global fund and Bill & Melinda Gates Foundation through its support to the ACT watch project
Dr Catherine Goodman works as a health economist at the London School of Hygiene & Tropical Medicine. Dr Goodman's research focuses on access to malaria treatment and health systems.